GNRH1 and posterior cortical atrophy: Despite a number of confounders and limitations, multiple real-world non-randomized studies and pooled data from RCTs demonstrated that LHRH antagonists were associated with a lower risk of CV events compared with LHRH agonists, especially in PCa patients with pre-existing CVD (61, 67–69, 73–75).